Cargando…

Central serous chorioretinopathy: Treatment

Central serous chorioretinopathy (CSC) is a pachychoroid spectrum disease characterized by serous detachment of the neurosensory retina with subretinal fluid in young and middle-aged adults. The pathogenesis of CSC is not yet fully understood. However, it is considered a multifactorial disease that...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jong Beom, Kim, Kiyoung, Kang, Min Seok, Kim, Eung Suk, Yu, Seung-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843567/
https://www.ncbi.nlm.nih.gov/pubmed/36660123
http://dx.doi.org/10.4103/2211-5056.362040
_version_ 1784870439089078272
author Park, Jong Beom
Kim, Kiyoung
Kang, Min Seok
Kim, Eung Suk
Yu, Seung-Young
author_facet Park, Jong Beom
Kim, Kiyoung
Kang, Min Seok
Kim, Eung Suk
Yu, Seung-Young
author_sort Park, Jong Beom
collection PubMed
description Central serous chorioretinopathy (CSC) is a pachychoroid spectrum disease characterized by serous detachment of the neurosensory retina with subretinal fluid in young and middle-aged adults. The pathogenesis of CSC is not yet fully understood. However, it is considered a multifactorial disease that is strongly associated with choroidal dysfunction or vascular engorgement. Although there is no consensus on the treatment of CSC, photodynamic therapy has been effectively used to manage serous retinal detachment (SRD) in CSC. Moreover, micropulse diode laser photocoagulation and focal laser treatment have also been used. Recently, oral medications, including mineralocorticoid receptor antagonists, have been proposed for the management of CSC. Multimodal imaging plays a significant role in the diagnosis and treatment of CSC. Optical coherence tomography angiography (OCTA) has the advantage of detecting vascular flow in the retina and choroid layer, allowing for a better understanding of the pathology, severity, prognosis, and chronicity of CSC. In addition, early detection of choroidal neovascularization in CSC is possible using OCTA. This review article aims to provide a comprehensive and updated understanding of CSC, focusing on treatment.
format Online
Article
Text
id pubmed-9843567
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-98435672023-01-18 Central serous chorioretinopathy: Treatment Park, Jong Beom Kim, Kiyoung Kang, Min Seok Kim, Eung Suk Yu, Seung-Young Taiwan J Ophthalmol Review Article Central serous chorioretinopathy (CSC) is a pachychoroid spectrum disease characterized by serous detachment of the neurosensory retina with subretinal fluid in young and middle-aged adults. The pathogenesis of CSC is not yet fully understood. However, it is considered a multifactorial disease that is strongly associated with choroidal dysfunction or vascular engorgement. Although there is no consensus on the treatment of CSC, photodynamic therapy has been effectively used to manage serous retinal detachment (SRD) in CSC. Moreover, micropulse diode laser photocoagulation and focal laser treatment have also been used. Recently, oral medications, including mineralocorticoid receptor antagonists, have been proposed for the management of CSC. Multimodal imaging plays a significant role in the diagnosis and treatment of CSC. Optical coherence tomography angiography (OCTA) has the advantage of detecting vascular flow in the retina and choroid layer, allowing for a better understanding of the pathology, severity, prognosis, and chronicity of CSC. In addition, early detection of choroidal neovascularization in CSC is possible using OCTA. This review article aims to provide a comprehensive and updated understanding of CSC, focusing on treatment. Wolters Kluwer - Medknow 2022-11-28 /pmc/articles/PMC9843567/ /pubmed/36660123 http://dx.doi.org/10.4103/2211-5056.362040 Text en Copyright: © 2022 Taiwan J Ophthalmol https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Review Article
Park, Jong Beom
Kim, Kiyoung
Kang, Min Seok
Kim, Eung Suk
Yu, Seung-Young
Central serous chorioretinopathy: Treatment
title Central serous chorioretinopathy: Treatment
title_full Central serous chorioretinopathy: Treatment
title_fullStr Central serous chorioretinopathy: Treatment
title_full_unstemmed Central serous chorioretinopathy: Treatment
title_short Central serous chorioretinopathy: Treatment
title_sort central serous chorioretinopathy: treatment
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843567/
https://www.ncbi.nlm.nih.gov/pubmed/36660123
http://dx.doi.org/10.4103/2211-5056.362040
work_keys_str_mv AT parkjongbeom centralserouschorioretinopathytreatment
AT kimkiyoung centralserouschorioretinopathytreatment
AT kangminseok centralserouschorioretinopathytreatment
AT kimeungsuk centralserouschorioretinopathytreatment
AT yuseungyoung centralserouschorioretinopathytreatment